Pharmaceutical compositions and dosage forms of thalidomide

Details for Australian Patent Application No. 2003290982 (hide)

International Classifications

Event Publications

8 April 2004 Complete Application Filed

Priority application(s): 60/426,016 14.11.02 US

15 July 2004 Application Open to Public Inspection

Published as AU-B-2003290982

2 July 2009 Application Accepted

Published as AU-B-2003290982

29 October 2009 Standard Patent Sealed

20 May 2010 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 20 Apr 2010. Address for service in Australia - Phillips Ormonde Fitzpatrick 367 Collins Street Melbourne VIC 3000 2004

15 July 2010 Extension of Term of Standard Patents

Celgene Corporation The earliest first regulatory approval date provided by the patentee 22 Dec 2009 For the goods THALOMID thalidomide

7 October 2010 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 20 Apr 2010 2004

17 November 2011 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 20 Apr 2010 2004

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.